Special Counsel Brian Sylvester was quoted in a Food Navigator-USA article, “FDA report on CBD seen as ‘disappointing’ recap of status quo,” about a report to Congress on CBD by FDA Commissioner Dr. Stephen Hahn.
Sylvester said the report suggests that FDA may be more focused on dietary supplements as a lawful regulatory pathway. “With the release of FDA’s report, we now know that FDA currently views dietary supplements as a potentially more viable pathway than food,” he said.
Related News
March 12, 2026
In the News
Louis Lehot Explores M&A's Growing Blitzhire Phenomenon
Foley & Lardner LLP partner Louis Lehot authors article on the emergence of blitzhires in the Mergers & Acquisitions article, “Blitzhires: The New Fast-Moving M&A Deal.”
March 4, 2026
In the News
Christopher Ward Analyzes Uncertain Future of State Captive‑Audience Laws
Foley & Lardner LLP partner Christopher Ward was quoted in the Law360 article, “State Captive Audience Bans Live On Despite Uncertainty,” analyzing the legal status and future prospects for state laws restricting captive audience meetings.
March 3, 2026
In the News
Patrick Daugherty Assesses Growing Popularity of Crypto ATMs
Foley & Lardner LLP partner Patrick Daugherty assessed the growing popularity of crypto ATMs in the C-Store Dive article, “Navigating the pros and cons of crypto ATMs for convenience retailers.”